Last updated: July 17, 2020
Sponsor: University Hospital, Caen
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT04480996
Pharmaco 20200619
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Case reported in the World Health Organization (WHO) database of individual safetycase reports to 01/03/2020
Adverse events reported were including the MedDRA terms: Road Traffic Accident (SMQ)
Patients treated with at least one liable nervous system drugs (ATC class N) or thatcan induce cognitive and pyschomotor undesirable effects by crossing the blood-brainbarrier (ATC class A04, C02A, L)
Exclusion
Exclusion Criteria:
- Chronology not compatible between the drug and the road traffic accident
Study Design
Total Participants: 500000
Study Start date:
March 01, 2020
Estimated Completion Date:
June 01, 2023
Study Description
Connect with a study center
Caen University Hospital, Department of Pharmacology
Caen, Normandie 14033
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.